Healthcare - Biotechnology - NASDAQ - US
$ 16.14
-5.34 %
$ 103 M
Market Cap
-1.86
P/E
CASH FLOW STATEMENT
22.7 M
OPERATING CASH FLOW
-69.1 M
INVESTING CASH FLOW
13.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Assembly Biosciences, Inc.
| Net Income | -61.2 M |
| Depreciation & Amortization | 450 K |
| Capital Expenditures | -255 K |
| Stock-Based Compensation | 5.12 M |
| Change in Working Capital | 76.3 M |
| Others | 86.7 M |
| Free Cash Flow | 22.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | (61.2) | (93.1) | (129.9) | (62.2) | (97.6) | (90.8) | (42.8) | (44.3) | (28.5) | (23.8) | (19.4) | (24.8) | (34.3) | (15.3) | (4.5) | (8.8) |
| Depreciation & Amortization | 0.5 | 0.5 | 0.5 | 0.7 | 0.5 | 0.6 | 0.2 | 80.3 K | 65 K | 11 K | 6.22 K | 4.62 K | 3.75 K | 12.5 K | 7.51 K | 4.65 K |
| Deferred Income Tax | (7.2) | 0 | (2.5) | 4 K | (0.8) | 1.1 | (9.1) | (0.6) | (7.8) | (0.7) | (1.7) | (3.2) | 0.3 | 2.3 | 0.1 | 0.7 |
| Stock Based Compensation | 5.1 | 6.6 | 5.2 | 21.9 | 20.6 | 28.5 | 8.6 | 5.0 | 7.9 | 11.3 | 1.7 | 3.2 | 3.0 | 2.4 | 0.1 | 0.5 |
| Other Operating Activities | 9.2 | 3.7 | 44.7 | 7.0 | 2.8 | (0.2) | 0.6 | 1.1 | 7.9 | 0.7 | 1.7 | 3.2 | 4.0 | 8.4 | 0.8 | 0.9 |
| Change in Working Capital | 76.3 | (2.1) | (11.4) | (30.3) | (9.5) | (4.2) | 44.3 | 3.8 | 1.8 | (2.5) | (0.1) | 0.2 | 2.0 | (3.1) | 39.9 K | 2.6 |
| Cash From Operations | 22.7 | (84.5) | (93.4) | (63.0) | (84.1) | (65.0) | 1.9 | (34.9) | (18.7) | (15.0) | (17.8) | (21.4) | (25.1) | (5.2) | (3.5) | (4.1) |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | (0.3) | (0.1) | (3.1) | (2.2) | (1.6) | (0.3) | (0.9) | (0.1) | 58.3 K | (0.1) | 6.48 K | 3.24 K | 12 K | 0 | 2.57 K | 2.88 K |
| Other Items | (68.9) | 90.7 | 29.6 | 70.3 | (48.8) | (135.1) | (14.8) | 36.3 | (64.8) | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (69.1) | 90.6 | 26.5 | 68.1 | (50.3) | (135.4) | (15.6) | 36.2 | (64.9) | 0.3 | 6.48 K | 3.24 K | 12 K | 0 | 2.57 K | 2.88 K |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.8) | 5.3 | 3.6 | 1.7 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.1 | 0.3 | 0.3 | 2.1 | 5.0 | 4.4 | 2.4 | 0 | 0.6 | 0 | 0 | 0.7 | 0.3 | (0.8) | 76.5 K | (0.3) |
| Cash From Financing Activities | 13.8 | 0.6 | 53.1 | 7.6 | 139.6 | 159.8 | 67.2 | 0.2 | 81.6 | 16.7 | 24.4 | 4.9 | 47.5 | 19.7 | 3.6 | 2.5 |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | (32.6) | 6.8 | (13.8) | 12.7 | 5.3 | (40.6) | 53.5 | 1.5 | (2.0) | 2.0 | 6.6 | (16.5) | 22.4 | 14.5 | 65.4 K | (1.7) |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | 22.5 | (84.6) | (96.5) | (65.2) | (85.6) | (65.3) | 1.0 | (35.0) | (18.8) | (15.1) | (17.8) | (21.4) | (25.1) | (5.2) | (3.5) | (4.2) |